253 related articles for article (PubMed ID: 10182705)
21. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 May; 64(94):26657-70. PubMed ID: 10558516
[TBL] [Abstract][Full Text] [Related]
22. Distribution of blood derivatives by registered blood establishments that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; delay of applicability date. Final rule; delay of applicability date.
Food and Drug Administration, HHS
Fed Regist; 2006 Nov; 71(218):66108-9. PubMed ID: 17099971
[TBL] [Abstract][Full Text] [Related]
23. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Nov; 65(216):66621-35. PubMed ID: 11503696
[TBL] [Abstract][Full Text] [Related]
24. Conforming regulations regarding removal of section 507 of the Federal Food, Drug, and Cosmetic Act; confirmation of effective date. Food and Drug Administration, HHS. Direct final rule; confirmation of effective date.
Fed Regist; 1999 May; 64(94):26657. PubMed ID: 10558515
[TBL] [Abstract][Full Text] [Related]
25. Registration of food facilities under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(190):57505-9. PubMed ID: 16200686
[TBL] [Abstract][Full Text] [Related]
26. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule.
Fed Regist; 1998 Oct; 63(195):54082-9. PubMed ID: 10185826
[TBL] [Abstract][Full Text] [Related]
27. Biologics products; establishment registration and product listing for manufacturers of human blood and blood products; amendment to exempt certain transfusion services from registration--FDA. Final rule.
Fed Regist; 1984 Aug; 49(171):34448-51. PubMed ID: 10299643
[TBL] [Abstract][Full Text] [Related]
28. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring; extension of comment period--FDA. Proposed rule; extension of comment period.
Fed Regist; 1998 Aug; 63(148):41219-20. PubMed ID: 10181522
[TBL] [Abstract][Full Text] [Related]
29. The Safe Medical Devices Act of 1990--FDA. Notice.
Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
[TBL] [Abstract][Full Text] [Related]
30. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
[TBL] [Abstract][Full Text] [Related]
31. Prior notice of imported food under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Nov; 73(217):66293-410. PubMed ID: 19112701
[TBL] [Abstract][Full Text] [Related]
32. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
[TBL] [Abstract][Full Text] [Related]
33. Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Dec; 63(239):68710-2. PubMed ID: 10187560
[TBL] [Abstract][Full Text] [Related]
34. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(107):33362-81. PubMed ID: 12785379
[TBL] [Abstract][Full Text] [Related]
35. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); companion document to direct final rule. Food and Drug Administration, HHS. Proposed rule.
Fed Regist; 1999 May; 64(93):26344-8. PubMed ID: 10558531
[TBL] [Abstract][Full Text] [Related]
36. Revision of the requirements for constituent materials. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Apr; 76(71):20513-8. PubMed ID: 21491807
[TBL] [Abstract][Full Text] [Related]
37. Postmarket surveillance. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
[TBL] [Abstract][Full Text] [Related]
38. Quality mammography standards; correcting amendment--FDA. Final rule; correcting amendment.
Fed Regist; 1998 Oct; 63(204):56555-9. PubMed ID: 10187116
[TBL] [Abstract][Full Text] [Related]
39. Medical devices; preemption of state product liability claims--FDA. Correction.
Fed Regist; 1997 Dec; 62(242):66179. PubMed ID: 10179302
[No Abstract] [Full Text] [Related]
40. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
Fed Regist; 1998 Jun; 63(104):29552-90. PubMed ID: 10179863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
